These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27401377)

  • 21. Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction.
    West RR; Jones DA; Henderson AH
    Heart; 2012 Apr; 98(8):637-44. PubMed ID: 22194152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study.
    Megiddo I; Chatterjee S; Nandi A; Laxminarayan R
    Glob Heart; 2014 Dec; 9(4):391-398.e3. PubMed ID: 25592792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective?
    Cadilhac DA; Carter R; Thrift AG; Dewey HM
    Stroke; 2012 May; 43(5):1370-5. PubMed ID: 22363058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.
    Lin L; Teng M; Zhao YJ; Khoo AL; Seet RC; Yong QW; Yeo TC; Lim BP
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):187-97. PubMed ID: 25860556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac rehabilitation costs.
    Moghei M; Turk-Adawi K; Isaranuwatchai W; Sarrafzadegan N; Oh P; Chessex C; Grace SL
    Int J Cardiol; 2017 Oct; 244():322-328. PubMed ID: 28622943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive cardiac rehabilitation: is it cost-effective?
    Oldridge NB
    Eur Heart J; 1998 Nov; 19 Suppl O():O42-50. PubMed ID: 9857950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Need cardiac rehabilitation be cost-effective?
    Perk J
    J Cardiovasc Risk; 1996 Apr; 3(2):167-71. PubMed ID: 8836858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The cost-benefit of cardiac rehabilitation programs].
    Coll R
    Rev Esp Cardiol; 1995; 48 Suppl 1():94-8. PubMed ID: 7644830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry.
    Ademi Z; Reid CM; Hollingsworth B; Stoelwinder J; Steg PG; Bhatt DL; Vale M; Liew D;
    Clin Ther; 2011 Oct; 33(10):1456-65. PubMed ID: 21982384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac rehabilitation and risk factor management after myocardial infarction. Clinical and economic evaluation.
    Oldridge NB
    Wien Klin Wochenschr; 1997; 109 Suppl 2():6-16. PubMed ID: 9286070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hepatitis B treatment: the cost-effectiveness of interferon compared to lamivudine.
    Almeida AM; da Silva AL; Cherchiglia ML; Andrade EI; de Oliveira GL; Acurcio Fde A
    Value Health; 2011; 14(5 Suppl 1):S24-8. PubMed ID: 21839893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J; Duke D; Goldman L; Pfeffer MA; Lamas GA; Soukup JR; Kuntz KM; Lee TH
    J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago, Chile.
    Araya R; Flynn T; Rojas G; Fritsch R; Simon G
    Am J Psychiatry; 2006 Aug; 163(8):1379-87. PubMed ID: 16877650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of a systematic guidelines-based approach to the prevention and management of vascular disease in a primary care setting.
    Kamboj L; Oh P; Levine M; Kammila S; Casey W; Harterre D; Goeree R
    Int J Cardiol; 2016 Jan; 203():893-9. PubMed ID: 26613572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cost effectiveness of captopril after myocardial infarct; comment].
    Szucs T; Berger K; Schulte-Hillen J; Kleber FX
    Med Klin (Munich); 1996 Feb; 91(2):112-8. PubMed ID: 8850108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
    Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
    Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
    Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
    Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.